For the best experience, please view the website in portrait mode.

News

CardioPrecision Makes Global Breakthrough In Robot-Assisted Heart Surgery

13.03.2024

CardioPrecision has played a leading role in bringing the world’s FIRST robotic aortic valve replacement through a tiny incision in the neck significantly closer to reality.

CardioPrecision recently demonstrated a proof-of-concept AVATAR (Advanced Videoscopic Aortic valve surgery by Transcervical Approach using Robot assistance) proc...

Read More

CardioPrecision Ltd Founder/CMO Awarded at ISMICS 2023

08.06.2023

CardioPrecision Founder and Chief Medical Officer Mr Fraser Sutherland has been honoured with a prestigious award at the 2023 ISMICS annual meeting in Boston, MA, USA.

The International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) annual meeting gathers pioneers, experts, and like-m...

Read More

CardioPrecision – Finalist for prestigious Scottish Life Sciences Awards

31.01.2023

CardioPrecision is proud to announce that it has received a nomination for an award at the Scotland’s Life Sciences Annual Awards.

CardioPrecision is one of three finalists under the Innovation - Health technology Category.

Scotland's Life Scie...

Read More

CardioPrecision Announces New Investment

31.10.2022

CardioPrecision Ltd, a technology company focussed on less invasive treatment of structural heart disease and cardiothoracic interventions, has received new investment. The equity financing was led by existing investors, principally London & Scottish Investment Partners, Discovery Investment Fund and Scottish Enterprise.

CardioPrec...

Read More

CardioPrecision Enters US Market

05.08.2022

CardioPrecision announces entry into the US market with its CoreVista® devices for use in Endoscopic Vessel Harvesting (EVH).

Coincident with the recent investment funding round, CardioPrecision performed first US cases at the prestigious Massachusetts General Hospital, in Boston, using its patented CoreVista® suite of devices.

Re...

Read More

CardioPrecision Launches CoreVista® Devices for Endoscopic Vessel Harvesting (EVH)

01.09.2021

CardioPrecision Ltd, a technology company developing medical devices for the treatment of structural heart disease and cardiothoracic interventions, has recently launched its suite of CoreVista® devices for use in Endoscopic Vessel Harvesting (EVH) during coronary artery bypass grafting (CABG) surgery. EVH is a technique whereby bypass conduits are harvested endoscopically from the limbs thro...

Read More

CardioPrecision Secures Further Investment

24.07.2020

CardioPrecision Ltd, the global leader in transcervical access for the treatment of structural heart disease and cardiothoracic interventions, received further investment. The equity financing was led by existing investors and the Scottish Investment Bank, the investment arm of Scottish Enterprise. CardioPrecision’s patented CoreVista® Technology facilitates access to the chest through a sho...

Read More

CardioPrecision Announces New TMVR Method Patent in the US

08.10.2019

CardioPrecision Ltd, the global leader in transcervical access for the treatment of structural heart disease and cardiothoracic intervention, announces the issuance of its latest patent ‘New Method and System for Transcatheter Intervention’ from the United States Patent and Trademark Office. CardioPrecision Founder and Chief Medical Officer, Mr Fraser Sutherland, MD, commented: “ We are ...

Read More

CardioPrecision Secures Further Investment

13.09.2019

CardioPrecision Ltd, the global leader in transcervical access for the treatment of structural heart disease and cardiothoracic intervention, successfully completed a further funding round from existing angel investors and Scottish Enterprise. “The success in raising this funding round in record time from the existing investors is a dramatic endorsement of the strength of the Company’s tran...

Read More

CardioPrecision Founders Awarded Prestigious Cutler’s Surgical Prize 2019

13.03.2019

Founders of CardioPrecision Ltd, the global leader in transcervical access for the treatment of structural heart disease and cardiothoracic intervention, received the closely coveted and prestigious Cutler’s Surgical Prize. CardioPrecision Founders Dr Ying Sutherland, PhD, and Mr Fraser Sutherland, MD, are honoured with award of the prestigious Cutler’s Surgical Prize by the Worshipful Comp...

Read More

CardioPrecision Ltd is certified to EN ISO 13485:2016

Cardio Precision Logo